Sugi Pharmacy
Sugi Pharmacy, officially known as Sugi Holdings Co., Ltd., is a prominent player in the Japanese pharmaceutical industry, headquartered in Japan. Established in 1976, the company has grown significantly, operating over 1,000 pharmacies across major regions, including Kanto and Kansai. Specialising in prescription medications, over-the-counter drugs, and health-related products, Sugi Pharmacy distinguishes itself through its commitment to customer service and community health. The company has achieved notable milestones, including the introduction of innovative health management services that cater to the evolving needs of its clientele. With a strong market position, Sugi Pharmacy is recognised for its extensive product range and dedication to enhancing the well-being of its customers, making it a trusted name in the healthcare sector.
DitchCarbon Score
How does Sugi Pharmacy's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sugi Pharmacy's score of 29 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sugi Pharmacy's reported carbon emissions
Sugi Pharmacy, headquartered in Japan, has made significant strides in addressing its carbon emissions. In 2022, the company reported total Scope 3 emissions of approximately 1,715,396,000 kg CO2e. This figure highlights the substantial impact of their supply chain and operational activities on their overall carbon footprint. Over the years, Sugi Pharmacy has demonstrated a commitment to reducing its emissions. For instance, in 2021, the company recorded Scope 1 emissions of about 1,832,000 kg CO2e and Scope 2 emissions of approximately 133,316,000 kg CO2e, leading to a combined total of around 135,149,000 kg CO2e for these two scopes. This reflects a proactive approach to managing direct and indirect emissions. Despite the absence of specific reduction targets or initiatives disclosed, Sugi Pharmacy's ongoing efforts to monitor and report emissions indicate a recognition of the importance of sustainability in the pharmaceutical industry. The company continues to engage in practices aimed at minimising its environmental impact, aligning with broader industry trends towards climate responsibility.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|
| Scope 1 | 1,769,000 | 0,000,000 | 0,000,000 | - |
| Scope 2 | 115,841,000 | 000,000,000 | 000,000,000 | - |
| Scope 3 | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sugi Pharmacy is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
